Rottapharm|Madaus is a multinational pharmaceutical company, headquartered in Monza, with more than 2.000 employees, branches in over 85 countries and seven manufacturing sites (located in Europe and India). Since its inception, the company has been primarily focused on research: R&D activities are currently engaged in different therapeutic areas such as gastroenterology, bronchopneumology, psychiatry, rheumatology, urology, gynecology, cardiovascular, oncology. The group also boats a leading position in the personal care and nutraceutical segments. With the acquisition of Biochemical PSN in 2005, Rottapharm became the leading Italian company in the sector of personal care products sold in pharmacies. In 2007, the acquisition of the German Madaus Pharma has represented an important turning point for the new Rottapharm|Madaus Group in terms of R&D synergies and marketing growth. In November of 2008, after the acquisition of Lay Line Genomics Spa., a branch of the company formed by the research laboratory of Basovizza (TS), Rottapharm Biotech S.r.l., a company of biotechnologies committed to the research and development of therapeutic agents based on recombined antibodies designed to cure severe pathologies, was created. Rottapharm|Madaus’s activities consist of the development of ethical pharmaceutical products: from prescription to over-the-counter, encompassing the areas of personal care and nutritional supplements. Rottapharm|Madaus's product portfolio is comprised of renowned brands such as Dona, Ananase, Epinitril, Estromineral, Saugella, Armolipid Agiolax, Reparil and Legalon. Rottapharm Biotech Srl was created after the acquisition from Lay Line Genomics SpA of the laboratory of biotechnological research of Basovizza (TS), as a company of biotechnologies committed to the research and development of therapeutic agents based on recombined antibodies designed to cure severe pathologies. Rottapharm Biotech utilizes the proprietary technology, coined SPLINT, to single out the therapeutic antibodies to be used in the cure of diseases of the muscular-skeletal system.

Acquired Companies: Madaus AG